Literature DB >> 25140365

Third-generation EGFR-TKIs—a new hope for NSCLC.

Rebecca Akkermans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25140365     DOI: 10.1016/s2213-2600(14)70095-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  1 in total

Review 1.  Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer.

Authors:  Wentao Tian; Chenghui Cao; Long Shu; Fang Wu
Journal:  Onco Targets Ther       Date:  2020-11-24       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.